India, July 22 -- China Pharma Holdings, Inc. (CPHI), a specialty pharmaceuticals company, said on Wednesday that it has priced a registered direct offering of 2.5 million common shares at $2.00 per share.
On the NYSE American, shares of China Pharma are currently losing 72.16 percent, changing hands at $2.2550.
Gross proceeds from the offering would be $5 million, the company said.
China Pharma plans to use the net proceeds for working capital and general corporate purposes.
The deal is set to close on or about July 23, 2026.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....